Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2019 Filed Jun 4, 2019 21:37 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 9,030 | $121.08 | $1,093,352.40 |
DisclosureSEC source: 0001093557-19-000144 · edgardoc.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,393 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 49,825 restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 31, 2019 Filed Jun 5, 2019 00:02 UTC |
SKYLER JAY SDirector
|
GrantCommon Stock | 2,729 | $0.00 | $2.73 |
DisclosureSEC source: 0001093557-19-000153 · wf-form4_155969295305043.xml · nonDerivative · entry 2 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,729 F2 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 2,729 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 5, 2019 00:01 UTC |
Collins Richard AlexanderDirector
|
GrantCommon Stock | 2,613 | $0.00 | $2.61 |
DisclosureSEC source: 0001093557-19-000152 · wf-form4_155969288108911.xml · nonDerivative · entry 2 Collins Richard Alexander · CIK 0001700619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,113 F2 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Included in this number are 2,613 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:57 UTC |
AUGUSTINOS NICHOLASDirector
|
GrantCommon Stock | 2,676 | $0.00 | $2.68 |
DisclosureSEC source: 0001093557-19-000149 · wf-form4_155969260951522.xml · nonDerivative · entry 1 AUGUSTINOS NICHOLAS · CIK 0001238485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,478 F1 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F2 · balance_after: Included in this number are 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:59 UTC |
KAHN BARBARADirector
|
GrantCommon Stock | 2,613 | $0.00 | $2.61 |
DisclosureSEC source: 0001093557-19-000151 · wf-form4_155969275804718.xml · nonDerivative · entry 2 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,613 F2 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 2,613 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:58 UTC |
TOPOL ERICDirector
|
GrantCommon Stock | 2,766 | $0.00 | $2.77 |
DisclosureSEC source: 0001093557-19-000150 · wf-form4_155969268158615.xml · nonDerivative · entry 2 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,766 F2 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 2,766 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:55 UTC |
FOLETTA MARK GDirector
|
GrantCommon Stock | 3,055 | $0.00 | $3.06 |
DisclosureSEC source: 0001093557-19-000148 · wf-form4_155969251078133.xml · nonDerivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,055 F3 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F4 · balance_after: Represents 3,055 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 23:53 UTC |
ALTMAN STEVEN RDirector
|
GrantCommon Stock | 2,676 | $0.00 | $2.68 |
DisclosureSEC source: 0001093557-19-000147 · wf-form4_155969242489886.xml · nonDerivative · entry 2 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,676 F2 · shares: The RSU Award was granted on May 31, 2019 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. F3 · balance_after: Represents 2,676 restricted stock units which were granted on May 31, 2019 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2020 Annual Meeting. Read SEC document |
| May 30, 2019 Filed Jun 5, 2019 00:02 UTC |
SKYLER JAY SDirector
|
OtherCommon Stock | 3,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000153 · wf-form4_155969295305043.xml · nonDerivative · entry 3 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Partnership Disclosed balance after: 56,223 F1 · shares: Shares were transferred from direct ownership to ownership under the Skyler Bach Family Limited Partnership, LLP, upon vesting of previously awarded restricted stock units. F4 · ownership.nature: Shares are held by Skyler Bach Family Limited Partnership, LLP, with respect to which the reporting person is a managing partner of the partnership and maintains voting rights of these shares. Read SEC document |
| May 30, 2019 Filed Jun 5, 2019 00:02 UTC |
SKYLER JAY SDirector
|
OtherCommon Stock | 3,607 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000153 · wf-form4_155969295305043.xml · nonDerivative · entry 1 SKYLER JAY S · CIK 0001236386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Skyler Bach Family Limited Partnership, LLP, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 30, 2019 Filed Jun 5, 2019 00:01 UTC |
Collins Richard AlexanderDirector
|
OtherCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000152 · wf-form4_155969288108911.xml · nonDerivative · entry 3 Collins Richard Alexander · CIK 0001700619 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 8,804 F1 · shares: Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. F4 · ownership.nature: Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. Read SEC document |
| May 30, 2019 Filed Jun 5, 2019 00:01 UTC |
Collins Richard AlexanderDirector
|
OtherCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000152 · wf-form4_155969288108911.xml · nonDerivative · entry 1 Collins Richard Alexander · CIK 0001700619 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · shares: Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:59 UTC |
KAHN BARBARADirector
|
OtherCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000151 · wf-form4_155969275804718.xml · nonDerivative · entry 3 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 20,266 F1 · shares: Shares were transferred from direct ownership to ownership under the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. F4 · ownership.nature: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:59 UTC |
KAHN BARBARADirector
|
OtherCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000151 · wf-form4_155969275804718.xml · nonDerivative · entry 1 KAHN BARBARA · CIK 0001520391 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:58 UTC |
TOPOL ERICDirector
|
OtherCommon Stock | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000150 · wf-form4_155969268158615.xml · nonDerivative · entry 3 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Holdings Disclosed balance after: 88,248 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by Topol Family Holdings, LLC, with respect to which the reporting person is a manager and maintains voting rights of these shares. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:58 UTC |
TOPOL ERICDirector
|
OtherCommon Stock | 3,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000150 · wf-form4_155969268158615.xml · nonDerivative · entry 1 TOPOL ERIC · CIK 0001468345 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Topol Family Holdings, LLC, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:55 UTC |
FOLETTA MARK GDirector
|
OtherCommon Stock | 4,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000148 · wf-form4_155969251078133.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 17,147 F1 · shares: Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. F2 · ownership.nature: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:55 UTC |
FOLETTA MARK GDirector
|
OtherCommon Stock | 4,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000148 · wf-form4_155969251078133.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:53 UTC |
ALTMAN STEVEN RDirector
|
OtherCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000147 · wf-form4_155969242489886.xml · nonDerivative · entry 3 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 53,804 F1 · shares: Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units. F4 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| May 30, 2019 Filed Jun 4, 2019 23:53 UTC |
ALTMAN STEVEN RDirector
|
OtherCommon Stock | 3,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-19-000147 · wf-form4_155969242489886.xml · nonDerivative · entry 1 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Shares were transferred from direct ownership to ownership under the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, upon vesting of previously awarded restricted stock units. Read SEC document |
| May 29, 2019 Filed May 30, 2019 20:56 UTC |
Blackford Quentin S.EVP Chief Financial Officer
|
SaleCommon Stock | 3,376 | $119.30 | $402,761.53 |
DisclosureSEC source: 0001093557-19-000134 · edgardoc.xml · nonDerivative · entry 2 Blackford Quentin S. · CIK 0001612451 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,740 F1 · shares: On February 27, 2019 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $119.18 to $119.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 90,869 unvested restricted stock units, 18,432 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| May 29, 2019 Filed May 30, 2019 20:56 UTC |
Blackford Quentin S.EVP Chief Financial Officer
|
SaleCommon Stock | 5,498 | $118.73 | $652,765.44 |
DisclosureSEC source: 0001093557-19-000134 · edgardoc.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · EVP Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,116 F1 · shares: On February 27, 2019 Mr. Blackford adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Blackford. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $118.18 to $119.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 90,869 unvested restricted stock units, 18,432 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 46,769 of which were granted on September 7, 2017 and shall vest through September 7, 2021. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:09 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 800 | $117.70 | $94,160.00 |
DisclosureSEC source: 0001093557-19-000129 · edgardoc.xml · nonDerivative · entry 3 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,774 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 49,825 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:09 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 1,285 | $116.93 | $150,256.59 |
DisclosureSEC source: 0001093557-19-000129 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,574 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $116.64 to $117.55. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 49,825 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:09 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 1,512 | $116.01 | $175,399.86 |
DisclosureSEC source: 0001093557-19-000129 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,859 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $115.55 to $116.11. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 49,825 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:09 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 1,100 | $117.65 | $129,410.05 |
DisclosureSEC source: 0001093557-19-000128 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 8,064 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $117.50 to $117.70. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| May 23, 2019 Filed May 24, 2019 21:09 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 916 | $116.86 | $107,041.84 |
DisclosureSEC source: 0001093557-19-000128 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 9,164 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.46 to $117.13. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| May 15, 2019 Filed May 17, 2019 22:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 400 | $122.73 | $49,090.52 |
DisclosureSEC source: 0001093557-19-000125 · edgardoc.xml · nonDerivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,095 F1 · shares: On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $122.49 to $122.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| May 15, 2019 Filed May 17, 2019 22:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 500 | $121.88 | $60,939.00 |
DisclosureSEC source: 0001093557-19-000125 · edgardoc.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,495 F1 · shares: On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $121.35 to $122.20. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| May 15, 2019 Filed May 17, 2019 22:22 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 100 | $118.65 | $11,865.00 |
DisclosureSEC source: 0001093557-19-000125 · edgardoc.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,995 F1 · shares: On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| May 13, 2019 Filed May 14, 2019 22:47 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 100 | $117.11 | $11,711.00 |
DisclosureSEC source: 0001093557-19-000123 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,100 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 116,618 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 53,696 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 27,093 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 13, 2019 Filed May 14, 2019 22:47 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 1,300 | $116.30 | $151,187.53 |
DisclosureSEC source: 0001093557-19-000123 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,200 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $116.01 to $116.94. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 116,618 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 53,696 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 27,093 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 13, 2019 Filed May 14, 2019 22:47 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 4,600 | $115.54 | $531,466.52 |
DisclosureSEC source: 0001093557-19-000123 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,500 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $115.00 to $115.99. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 116,618 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 53,696 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 27,093 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| May 10, 2019 Filed May 13, 2019 21:51 UTC |
Murphy Patrick MichaelSVP Legal Affairs
|
SaleCommon Stock | 400 | $116.92 | $46,768.00 |
DisclosureSEC source: 0001093557-19-000121 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,860 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 22:06 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 4,797 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001093557-19-000112 · edgardoc.xml · derivative · entry 3 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,797 shares Expires 2019-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2019 Filed Apr 25, 2019 22:06 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
Exercise / conversionCommon Stock | 4,797 | $7.27 | $34,874.19 |
DisclosureSEC source: 0001093557-19-000112 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Included in this number are 42,760 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 20,062 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 7,711 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 23:58 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 1,200 | $117.27 | $140,724.00 |
DisclosureSEC source: 0001093557-19-000110 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,080 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $117.25 to $117.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 23:58 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 816 | $116.56 | $95,114.02 |
DisclosureSEC source: 0001093557-19-000110 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,280 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.25 to $117.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 23:58 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 1,300 | $117.21 | $152,375.99 |
DisclosureSEC source: 0001093557-19-000109 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,371 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $117.00 to $117.25. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 49,825 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 23, 2019 Filed Apr 24, 2019 23:58 UTC |
Pacelli Steven RobertEVP Strategy and Corporate Dev
|
SaleCommon Stock | 2,296 | $116.27 | $266,952.94 |
DisclosureSEC source: 0001093557-19-000109 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · EVP Strategy and Corporate Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,671 F1 · shares: On June 11, 2018, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $115.75 to $116.67. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 49,825 unvested restricted stock units, 14,987 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:37 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 3,980 | $119.56 | $475,844.42 |
DisclosureSEC source: 0001093557-19-000097 · edgardoc.xml · nonDerivative · entry 3 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,100 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $119.08 to $119.91. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 116,618 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 53,696 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 27,093 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:37 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 900 | $118.28 | $106,448.04 |
DisclosureSEC source: 0001093557-19-000097 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,080 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $117.91 to $118.76. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 116,618 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 53,696 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 27,093 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 21:37 UTC |
SAYER KEVIN RDirector · President, CEO and Chairman
|
SaleCommon Stock | 1,120 | $117.12 | $131,178.43 |
DisclosureSEC source: 0001093557-19-000097 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · President, CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,980 F1 · shares: On May 10, 2018, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $116.67 to $117.47. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 116,618 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 53,696 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 27,093 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 21:20 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 599 | $119.36 | $71,496.58 |
DisclosureSEC source: 0001093557-19-000100 · edgardoc.xml · nonDerivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,095 F1 · shares: On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $119.05 to $119.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 21:20 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 301 | $118.88 | $35,783.99 |
DisclosureSEC source: 0001093557-19-000100 · edgardoc.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,694 F1 · shares: On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $118.00 to $119.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| April 15, 2019 Filed Apr 17, 2019 21:20 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 100 | $116.96 | $11,696.00 |
DisclosureSEC source: 0001093557-19-000100 · edgardoc.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 14,995 F1 · shares: On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee. Read SEC document |
| April 10, 2019 Filed Apr 12, 2019 21:50 UTC |
Murphy Patrick MichaelSVP Legal Affairs
|
SaleCommon Stock | 400 | $115.05 | $46,020.00 |
DisclosureSEC source: 0001093557-19-000095 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · SVP Legal Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,260 F1 · shares: On June 15, 2018, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 26,711 unvested restricted stock units, 11,714 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 11,210 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 3,787 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 23:09 UTC |
ALTMAN STEVEN RDirector
|
SaleCommon Stock | 2,500 | $119.60 | $298,999.00 |
DisclosureSEC source: 0001093557-19-000093 · edgardoc.xml · nonDerivative · entry 1 ALTMAN STEVEN R · CIK 0001191307 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 50,355 F1 · shares: On August 6, 2018, Mr. Altman adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Altman. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $119.11 to $119.95. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Steven R. and Lisa J. Altman, TTEE's Altman Family Trust DTD 8/21/92, with respect to which the reporting person is a trustee. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 21:40 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 1,400 | $127.77 | $178,884.44 |
DisclosureSEC source: 0001093557-19-000091 · edgardoc.xml · nonDerivative · entry 2 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,096 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $127.01 to $128.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 51,203 unvested restricted stock units, 16,365 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
| March 25, 2019 Filed Mar 27, 2019 21:40 UTC |
DOUBLEDAY RICHARDEVP Chief Commercial Officer
|
SaleCommon Stock | 616 | $126.47 | $77,904.97 |
DisclosureSEC source: 0001093557-19-000091 · edgardoc.xml · nonDerivative · entry 1 DOUBLEDAY RICHARD · CIK 0001466545 · EVP Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,496 F1 · shares: On June 1, 2018, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $126.01 to $127.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 51,203 unvested restricted stock units, 16,365 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 25,668 of which were granted on March 8, 2018 and shall vest through March 8, 2021 and 9,170 of which were granted on March 8, 2017 and shall vest through March 8, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.